Kaitlyn Cartwright, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Sanofi
    Topic:
    Clinical Trial
    Date added:
    08/04/2026
    Date updated:
    08/05/2026
    Relationship end date:
    04/01/2026
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Zenas Biopharma
    Topic:
    Clinical Trial
    Date added:
    08/04/2026
    Date updated:
    08/05/2026
Return to 08/12/2026 - Pediatric Onset Multiple Sclerosis: Updates on Treatment Options